Edition:
United States

Minerva Neurosciences Inc (NERV.OQ)

NERV.OQ on NASDAQ Stock Exchange Global Market

8.40USD
16 Nov 2018
Change (% chg)

$0.10 (+1.20%)
Prev Close
$8.30
Open
$8.21
Day's High
$8.54
Day's Low
$8.21
Volume
42,216
Avg. Vol
55,344
52-wk High
$12.95
52-wk Low
$5.03

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.310
Jun '18 0.00 -0.323
Mar '18 0.00 -0.320
FY 2017 Dec '17 0.00 -0.239
Sep '17 0.00 -0.275
Jun '17 0.00 -0.266
Mar '17 0.00 -0.301
FY 2016 Dec '16 0.00 -0.270
Sep '16 0.00 -0.242
Jun '16 0.00 -0.179
Mar '16 0.00 -0.294
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 3 -0.39 -0.33 -0.45 -0.40
Year Ending Dec-18 3 -1.35 -1.28 -1.42 -1.44
Year Ending Dec-19 3 -1.45 -1.27 -1.60 -1.44
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 79.36 29.34
P/E High - Last 5 Yrs. -- 265.87 45.80
P/E Low - Last 5 Yrs. -- 84.08 25.31
Beta 1.64 0.73 0.91
Price to Sales (TTM) -- 217.51 20.58
Price to Book (MRQ) 3.12 16.40 4.23
Price to Tangible Book (MRQ) 6.05 20.76 12.86
Price to Cash Flow (TTM) -- 48.38 21.19
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.42 1.65
Dividend Yield - 5 Year Avg -- 0.23 1.43
Dividend 5 Year Growth Rate -- 3.73 -8.12
Payout Ratio(TTM) -- 7.92 43.70

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 147.95 6.76
Sales (TTM) vs TTM 1 Yr. Ago -- 61.16 5.37
Sales - 5 Yr. Growth Rate -- 22.11 7.50
EPS (MRQ) vs Qtr. 1 Yr. Ago -12.53 79.14 28.07
EPS (TTM) vs TTM 1 Yr. Ago -7.19 -- --
EPS - 5 Yr. Growth Rate -- 20.47 7.61
Capital Spending - 5 Yr. Growth Rate -- 34.50 8.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.42 2.60
Current Ratio (MRQ) 26.20 6.52 3.62
LT Debt to Equity (MRQ) 0.00 18.23 9.93
Total Debt to Equity (MRQ) 0.00 24.16 13.84
Interest Coverage (TTM) -190.70 -167.48 35.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 30.41 53.45
Gross Margin - 5 Yr. Avg. -- 47.56 52.35
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -157.21 16.19
Operating Margin (TTM) -- -1,764.99 -12.21
Operating Margin - 5 Yr. Avg. -- -170.35 11.73
Pre-Tax Margin (TTM) -- -1,697.68 -10.76
Pre-Tax Margin - 5 Yr. Avg. -- -173.02 12.03
Net Profit Margin (TTM) -- -1,693.54 -14.16
Net Profit Margin - 5 Yr. Avg. -- -173.38 8.29
Effective Tax Rate (TTM) -- 14.72 21.78
Effective Tax Rate - 5 Yr. Avg. -- 19.72 24.36

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,455,811 843,940,439
Net Income/Employee (TTM) -3,850,530 -3,607,800 98,316,310
Receivable Turnover (TTM) -- 8.35 5.42
Inventory Turnover (TTM) -- 2.90 4.00
Asset Turnover (TTM) 0.00 0.48 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -26.86 -0.72 10.84
Return on Assets - 5 Yr. Avg. -39.30 2.40 11.60
Return on Investment (TTM) -27.88 -0.30 13.58
Return on Investment - 5 Yr. Avg. -41.72 2.31 14.86
Return on Equity (TTM) -39.91 -2.98 15.11
Return on Equity - 5 Yr. Avg. -53.29 -1.50 16.02
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -9.50 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Minerva Neurosciences Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -23.69 -21.23 18 91
13 Week -2.98 1.22 68 93
26 Week 22.56 22.07 85 91
52 Week 64.65 56.34 88 98
YTD 34.71 32.31 83 91
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 89.41%
# of Holders: 127
Total Shares Held: 34,756,314
3 Mo. Net Change: 4,097,024
# New Positions: 20
# Closed Positions: 6
# Increased Positions: 69
# Reduced Positions: 27
# Net Buyers: 42
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.